U.S. President Donald Trump announced plans to impose tariffs on oil and gas imports, expected to take effect around February 18. While he did not specify which countries would be affected, he indicated that the tariff on Canadian crude could be reduced to 10%, down from the previously mentioned 25%.
The U.S. imports approximately 4 million barrels per day of Canadian oil, with about 70% processed by refiners in the Midwest. Analysts warn that imposing tariffs could increase fuel costs and reduce production at refineries reliant on heavier crude from Canada and Mexico. Many refiners in the region, including Phillips 66, HF Sinclair, and Par Pacific Holdings, could face supply disruptions if tariffs take effect.
Phillips 66 has stated that production cuts may occur in the Midwest and Rocky Mountain region due to limited alternative crude sources. Meanwhile, Valero, the second-largest U.S. refiner, is preparing for multiple scenarios. "Our teams are working on strategies to mitigate the impact of Trump's tariffs," said Valero COO Gary Simmons.
Earlier this month, U.S. crude imports from Canada reached record levels. However, with the looming tariffs, refiners are bracing for potential operational challenges and cost increases. The oil industry now awaits further details on the administration’s final tariff decision.


Bitcoin Whales Acquire $4.3B in BTC Amid Market Decline, Signaling Potential Bottom
Hyundai Motor Shares Surge on Nvidia Partnership Speculation
Apple Loses Top Spot in China's Smartphone Market Amid Rising Competition
Senate Vote Looms on Blocking Trump’s Military Action in Venezuela
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
S&P 500 Rises Amid Cyclical Stock Gains, Inflation Data Looms
Trump Administration Launches New DOJ Division to Fight Nationwide Fraud
Deutsche Bank Warns of Persistent Inflation Risks in 2025
U.S. Judge Blocks Trump Administration’s $10 Billion Federal Funding Freeze to Democratic States
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Bullish Start for S&P 500 Sparks Optimism for 2025, Despite Risks
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
EU Set to Approve Historic Mercosur Trade Deal Amid Farmer Protests
Trump Says Taiwan Decision Is “Up to Xi,” Warns Against Changing Status Quo
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 



